Phytomedicines modulate pyroptosis in cardiovascular diseases: pre-clinical evidence, limitations and translational perspectives

Zichen Zhu, Huici Zhu, Zhuoyue Zhang, Jiaying Hu, Baonian Liu, Haidong Guo · 2026

Read Phytomedicines modulate pyroptosis in cardiovascular diseases: pre-clinical evidence, limitations and translational perspectives by Zichen Zhu, Huici Zhu, Zhuoyue Zhang, Jiaying Hu, Baonian Liu, Haidong Guo (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13601353.txt.

Description

Zichen Zhu and co-authors reviewed plant medicines that calm a fiery form of cell death in heart disease in a 2026 paper. Cardiovascular disease remains the world's top cause of disability and early death despite modern drugs. Pyroptosis, a programmed cell death that spills inflammatory signals, feeds the vessel and heart damage behind many of those deaths.

Preclinical studies test whether phytomedicines, compounds from medicinal plants, can dial that death pathway down. The review weighs the evidence, its limits, and what translation to patients would require. Honest stocktaking matters here: cell and animal promise often evaporates in human trials. The authors map which plant compounds deserve the expense of proper clinical testing.

Catalog record

CREATORZichen Zhu, Huici Zhu, Zhuoyue Zhang, Jiaying Hu, Baonian Liu, Haidong Guo
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE92 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13601353

Browse the full library · About the Tower of Babel